SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640455-20-000103
Filing Date
2020-08-07
Accepted
2020-08-07 18:23:30
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q jnce-20200630.htm   iXBRL 10-Q 1780014
2 EX-31.1 jnce06302020exhibit311.htm EX-31.1 11515
3 EX-31.2 jnce06302020exhibit312.htm EX-31.2 11523
4 EX-32.1 jnce06302020exhibit321.htm EX-32.1 11077
  Complete submission text file 0001640455-20-000103.txt   4997805

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20200630.xsd EX-101.SCH 30221
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20200630_cal.xml EX-101.CAL 58811
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20200630_def.xml EX-101.DEF 185339
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20200630_lab.xml EX-101.LAB 453309
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20200630_pre.xml EX-101.PRE 298822
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37998 | Film No.: 201085818
SIC: 2836 Biological Products, (No Diagnostic Substances)